What do low PEG ratios tell us about these FTSE 100 shares?

The PEG ratio is often overlooked by investors — maybe because it takes a little longer to work out than the P/E ratio. What does it say about these FTSE 100 shares?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Young black colleagues high-fiving each other at work

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

FTSE 100 shares are frequently described as cheap by analysts, and have been for a while. That’s often backed up by the price-to-earnings, the price-to-sales ratio, and the price-to-book ratio.

However, we shouldn’t invest because of a company’s performance last year. And we’re not investing just for the next 12 months. It’s about how a company will perform throughout the medium and long term.

PEG ratios

Thus, growth is central to the equation. That’s where the PEG ratio can help us. This metric provides a valuable tool for investors seeking to assess a company’s growth potential in relation to its current valuation.

The PEG ratio, or price/earnings-to-growth ratio, takes into account both the price-to-earnings (P/E) ratio and the expected earnings growth rate.

A PEG ratio of 1 is often considered indicative of fair value, suggesting that the stock’s price is in line with its anticipated growth.

Ratios below 1 may suggest that the stock is undervalued relative to its growth prospects, while ratios some distance above 1 may indicate potential overvaluation.

Nonetheless, this is just a rule of thumb and it’s often prudent to compare companies within the same sector. For example, the PEG ratio is often calculated using annualised growth rates over five years and some industries may see tailwinds further into the long run.

By incorporating expected earnings growth into the assessment, the PEG ratio offers a more comprehensive view than the P/E ratio alone. This is particularly relevant in industries or sectors where high-growth companies might justify higher valuations.

FTSE 100 shares with low PEGs

As noted above, it can pay to compare companies within the same industry. However, the below data provides us with an insight into some of the cheapest stocks on the index. This is just a handful of stocks with PEG ratios that looks pretty attractive.

PEG Forward
AstraZeneca 1.5
Burberry1.4
Hikma1.2
Lloyds0.5
Rolls-Royce0.5
Smith & Nephew1.4
FTSE 100 shares: PEG ratios

This PEG data can be used as the basis to make informed investment decisions. However, the PEG ratio does have one main drawback. That’s the fact it’s reliant on estimated future growth rates. These estimates are subjective and can vary among analysts, introducing a degree of uncertainty into the calculation.

However, the above data broadly reiterates widely-shared sentiment that companies like Lloyds and Rolls-Royce are undervalued. It also provides us with important data about stocks that are less frequently considered, including generics manufacturer Hikma.

AstraZeneca is another interesting company to see on this list. The pharma giant trades around 30 times earnings, but analysts anticipate this R&D-driven business to continue growing an impressive rate throughout the medium term.

It’s also possible that AstraZeneca, Hikma, and Smith & Nephew will continue growing strongly beyond the medium term. This is because there’s a broad understanding that ageing global populations will cause demand for new drugs, generic products, and medical devices, to surge.

As such, from my notes above, it’s clear that the PEG ratio is good starting point for assessing stocks and making informed investment decisions.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

James Fox has positions in AstraZeneca Plc, Lloyds Banking Group Plc and Smith & Nephew Plc. The Motley Fool UK has recommended AstraZeneca Plc, Burberry Group Plc, Hikma Pharmaceuticals Plc, Lloyds Banking Group Plc, and Smith & Nephew Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Passive income text with pin graph chart on business table
Dividend Shares

How to invest £20,000 in 2025 to generate safe passive income

It’s easy to generate passive income from the stock market today. Here’s how Edward Sheldon thinks investors should build an…

Read more »

Runner standing at the starting point with 2025 year for starting in new year 2025 to achieve business planing and success concept.
Investing Articles

Could the FTSE 100 hit 9,000 in 2025?

The FTSE 100 has lagged other indexes over the last year. But some commentators believe 2025 could be a stellar…

Read more »

Investing Articles

Why selling cars could drive the Amazon share price higher in 2025

After outperforming the S&P 500 in 2024, Stephen Wright's looking at what could push the Amazon share price to greater…

Read more »

Pink 3D image of the numbers '2025' growing in size
Investing Articles

3 of the best British shares to consider buying for 2025

Looking for UK shares to think about buying next year? These three stocks have all been brilliant long-term investments but…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

5 crucial Warren Buffett investing habits and a stock to consider buying now

Here's a UK stock idea that looks like it's offering the kind of good value sought by US billionaire investor…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Investing Articles

2 legendary FTSE 250 shares I won’t touch with a bargepole in 2025

Roland Head looks at two household names and explains why these FTSE 250 shares are already on his list of…

Read more »

Investing Articles

Why I think the Barclays share price is still a bargain heading into 2025

Stephen Wright thinks a combination of dividends and share buybacks means the Barclays share price is still attractive, despite a…

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

Here’s how an investor could use £10 a day to target a £2,348 second income

For just a tenner a day, our writer illustrates how an investor could build a four-figure annual second income over…

Read more »